Five things for pharma marketers to know: Friday, September 22, 2023
Big Pharma loves antibody-drug conjugates; AstraZeneca sued over work-from-home policy; HHS bars Wuhan Institute of Virology from receiving federal funds.
Stay updated with breaking news from Elmarie Bodes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Big Pharma loves antibody-drug conjugates; AstraZeneca sued over work-from-home policy; HHS bars Wuhan Institute of Virology from receiving federal funds.
AstraZeneca Pharmaceuticals LP has been sued in the U.S. by a former senior director who claims the drugmaker refused to pay her nearly $130,000 in promised bonuses and stock options because she worked from home full-time. Elmarie Bodes, who was AstraZeneca's senior director of business transformation until January, said in the lawsuit filed in South Carolina state court on Tuesday that she was owed a $124,000 performance bonus and $65,000 in stock options. Instead, AstraZeneca earlier this year cut her payout in half and refused to grant any stock options because she did not come into ...